Amplicon details |
||
Amplicon: |
195 bp | |
1 gcacctacaa atgccatcat tgcgataaag gaaaggctat cgttcaagat 51 gcctctgccg acagtggtcc caaagatgga cccccaccca cgaggagcat 101 cgtggaaaaa gaagacgttc caaccacgtc ttcaaagcaa gtggattgat 151 gtgatatctc cactgacgta agggatgacg cacaatccca ctatc |
||
| Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
|---|---|---|---|---|---|---|---|
| NRN_DM094783 | nrnl1 | Method for screening for plants wit... | 17236 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| GY348596.1 | emblrelpat | Sequence 10 from patent US 8008544. | 3900 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| NRN_DI001984 | nrnl1 | PRODUCTION OF BIOLOGICALLY ACTIVE I... | 5013 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| AX052539.1 | emblrelpat | Sequence 1 from Patent WO0071668. | 12614 bp | synthetic construct | QL-ELE-00-005 | 195 bp | View |
| MI866522.1 | emblrelpat | Sequence 134 from patent US 10017773. | 12194 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| NRN_DI001458 | nrnl1 | PRODUCTION OF BIOLOGICALLY ACTIVE I... | 4727 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| NRN_DI001458 | nrnl1 | PRODUCTION OF BIOLOGICALLY ACTIVE I... | 4727 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| AX063413.1 | emblrelpat | Sequence 5 from Patent WO0100833. | 7599 bp | synthetic construct | QL-ELE-00-005 | 195 bp | View |
| NRN_BD172072 | nrnl1 | Improvements in or relating to orga... | 444 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| NRN_DI104332 | nrnl1 | A TRANSFORMATION METHOD FOR VIVIPAR... | 12361 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| GY348597.1 | emblrelpat | Sequence 11 from patent US 8008544. | 4680 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| NRN_EA324114 | nrnl1 | Sequence 12 from patent US 7303917. | 1334 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| MV669214.1 | emblrelpat | Sequence 23 from patent US 10767201. | 13992 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| NRN_CS101323 | nrnl1 | Sequence 13 from Patent WO200504751... | 781 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| GY348598.1 | emblrelpat | Sequence 12 from patent US 8008544. | 5490 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| HK333091.1 | emblrelpat | Sequence 6 from patent US 8569579. | 9311 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| NRN_GV655019 | nrnl1 | Sequence 2 from patent US 7667023. | 351 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| NRN_GX386309 | nrnl1 | Sequence 243 from patent US 7763775. | 10905 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| MI866523.1 | emblrelpat | Sequence 135 from patent US 10017773. | 12187 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
| NRN_GX386308 | nrnl1 | Sequence 242 from patent US 7763775. | 10821 bp | unidentified | QL-ELE-00-005 | 195 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.